作者:
Dennis D H,Kim [1]
;
Igor,Novitzky-Basso [1]
;
Taehyung S,Kim [1]
;
Eshetu G,Atenafu [2]
;
Donna,Forrest [3]
;
Lynn,Savoie [4]
;
Isabelle,Bence-Bruckler [5]
;
Mary-Margaret,Keating [6]
;
Lambert,Busque [7]
;
Robert,Delage [8]
;
Anargyros,Xenocostas [9]
;
Elena,Liew [10]
;
Kristjan,Paulson [11]
;
Tracy,Stockley [12]
;
Pierre,Laneuville [13]
;
Jeffrey H,Lipton [14]
;
Suzanne,Kamel-Reid [1]
;
Brian,Leber [13]
作者单位:
Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada.
[1]
Department of Computer Science, Donnelly Centre, University of Toronto, Toronto, Canada.
[2]
Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
[3]
Leukemia/BMT Program of British Columbia, Division of Hematology, Vancouver General Hospital, British Columbia Cancer Agency, and University of British Columbia, Vancouver, Canada.
[4]
University of Calgary, Alberta Health Services, Calgary, Canada.
[5]
Medicine, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, Canada.
[6]
Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Canada.
[7]
Hematopoiesis and Aging Research Unit, University of Montreal, Hôpital Maisonneuve-Rosemont, Montreal, Canada.
[8]
Centre Universitaire d'Hématologie et d'Oncologie de Québec, CHU de Québec, Hôpital de l'Enfant-Jésus, Québec, Canada.
[9]
Department of Medicine, Division of Hematology, London Health Sciences Centre, University of Western Ontario, London, Canada.
[10]
Department of Medicine, University of Alberta, Edmonton, Canada.
[11]
CancerCare Manitoba, Winnipeg, Manitoba, Canada.
[12]
Department of Pathology, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada.
[13]
Division of Hematology, McGill University Health Centre, Montreal, Canada.
[14]
Department of Oncology, McMaster University, Hamilton, Canada.
[15]
DOI
10.1111/bjh.17447
PMID
33876423
发布时间
2021-09-28